CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Fresenius Kabi USA, LLC recalls Tyenne (tocilizumab-aazg) Injection

Read the official FDA notice

Published
2 Sept 2026
Units affected
4,643 20mL-vials
Agency
FDA
Country
United States

The hazard

Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.

Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois, 60047, NDC 65219-594-20.

Brand / company
Fresenius Kabi USA, LLC
Codes / lots
Lot: 16UI07, Exp 08/31/2028
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 2 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.